Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEAMERICAN:CTMNASDAQ:NRCNASDAQ:OABINASDAQ:TRVG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCTMCastellum$1.07+3.9%$1.04$0.12▼$2.83$88.62M-10.113.85 million shs1.71 million shsNRCNational Research$17.00+2.7%$13.53$9.76▼$27.07$377.10M0.3894,842 shs101,163 shsOABIOmniAb$1.61+1.3%$1.59$1.22▼$4.96$194.20M-0.02664,597 shs438,529 shsTRVGTrivago N.V. ADS$3.83-1.3%$4.20$1.60▼$5.83$272.79M1.4295,629 shs39,652 shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCTMCastellum+3.88%-9.32%+3.88%-12.30%+484.38%NRCNational Research+2.72%+2.22%+25.09%+23.91%-32.99%OABIOmniAb+1.26%-8.00%+16.67%-34.02%-59.65%TRVGTrivago N.V. ADS-1.29%-1.79%-8.81%-26.06%+89.60%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCTMCastellum3.3799 of 5 stars3.55.00.00.03.42.50.0NRCNational Research1.4534 of 5 stars0.02.01.70.01.52.51.3OABIOmniAb3.0287 of 5 stars3.51.00.00.02.73.31.3TRVGTrivago N.V. ADS1.7082 of 5 stars2.15.00.00.02.90.00.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCTMCastellum 3.00Buy$3.00180.37% UpsideNRCNational Research 0.00N/AN/AN/AOABIOmniAb 3.00Buy$7.00334.78% UpsideTRVGTrivago N.V. ADS 2.25Hold$4.7323.37% UpsideCurrent Analyst Ratings BreakdownLatest CTM, NRC, TRVG, and OABI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/12/2025OABIOmniAbBenchmarkSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$6.00 ➝ $6.005/5/2025TRVGTrivago N.V. ADSSusquehannaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$3.50 ➝ $5.505/1/2025TRVGTrivago N.V. ADSB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$4.00 ➝ $5.504/28/2025TRVGTrivago N.V. ADSUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$3.10 ➝ $3.404/24/2025CTMCastellumMaxim GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetBuy$3.004/24/2025CTMCastellumMaxim GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy$3.004/23/2025CTMCastellumUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong Sell ➝ Hold3/27/2025OABIOmniAbRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$7.00 ➝ $4.00(Data available from 6/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCTMCastellum$44.76M2.06N/AN/A$0.29 per share3.69NRCNational Research$143.06M2.71$1.37 per share12.40$1.36 per share12.50OABIOmniAb$26.39M7.45N/AN/A$2.37 per share0.68TRVGTrivago N.V. ADS$498.74M0.54$0.06 per share65.18$3.04 per share1.26Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCTMCastellum-$9.98M-$0.17N/A∞N/A-15.61%-40.01%-20.51%7/15/2025 (Estimated)NRCNational Research$24.78M$1.0316.51∞N/A17.14%71.33%18.67%7/28/2025 (Estimated)OABIOmniAb-$62.03M-$0.58N/AN/AN/A-229.11%-21.37%-18.84%8/6/2025 (Estimated)TRVGTrivago N.V. ADS-$25.64M-$0.01N/A191.50N/A-4.82%0.52%0.33%7/29/2025 (Estimated)Latest CTM, NRC, TRVG, and OABI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025OABIOmniAb-$0.17-$0.17N/A-$0.17$4.49 million$4.15 million4/28/2025Q1 2025NRCNational ResearchN/A$0.25N/A$0.25N/A$33.55 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCTMCastellumN/AN/AN/AN/AN/ANRCNational Research$0.482.82%N/A46.60%N/AOABIOmniAbN/AN/AN/AN/AN/ATRVGTrivago N.V. ADSN/AN/AN/AN/AN/ALatest CTM, NRC, TRVG, and OABI DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/25/2025NRCNational Researchquarterly$0.124.1%6/27/20256/27/20257/11/20253/24/2025NRCNational Researchquarterly$0.123.27%3/28/20253/28/20254/11/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCTMCastellum0.252.922.92NRCNational Research1.980.540.54OABIOmniAbN/A4.704.70TRVGTrivago N.V. ADSN/A3.213.21Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCTMCastellum3.39%NRCNational Research47.26%OABIOmniAb72.08%TRVGTrivago N.V. ADS4.50%Insider OwnershipCompanyInsider OwnershipCTMCastellum29.79%NRCNational Research2.00%OABIOmniAb8.60%TRVGTrivago N.V. ADS6.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCTMCastellum20786.04 million60.41 millionNot OptionableNRCNational Research49022.78 million22.33 millionOptionableOABIOmniAb7122.14 million111.63 millionOptionableTRVGTrivago N.V. ADS71070.31 million65.74 millionOptionableCTM, NRC, TRVG, and OABI HeadlinesRecent News About These CompaniesShort Interest in Trivago N.V. ADS (NASDAQ:TRVG) Decreases By 29.9%June 19, 2025 | americanbankingnews.comtrivago (NASDAQ:TRVG) Sees Large Drop in Short InterestJune 17, 2025 | marketbeat.comCompagnie Lombard Odier SCmA Grows Stock Position in trivago (NASDAQ:TRVG)June 13, 2025 | marketbeat.comTrivago watched its revenue forecast plummet from $1 billion to nearly zero—so the company tapped a set of former interns to turn it aroundJune 13, 2025 | msn.comUniversal Beteiligungs und Servicegesellschaft mbH Invests $628,000 in trivago (NASDAQ:TRVG)June 4, 2025 | marketbeat.comTrivago (TRVG) Is Attractively Priced Despite Fast-paced MomentumMay 29, 2025 | zacks.comtrivago (NASDAQ:TRVG) Trading Down 2.3% - What's Next?May 29, 2025 | marketbeat.comTrivago: Some countries shunning US travelMay 28, 2025 | travelmole.comtrivago N.V. Announces Annual General Meeting of ShareholdersMay 22, 2025 | globenewswire.comtrivago Announces 2025 Shareholder MeetingMay 22, 2025 | tipranks.comTrivago’s millennial CEO says he never had a career plan: ‘I just followed where the energy was’May 14, 2025 | finance.yahoo.comTrivago’s millennial CEO says he never had a career plan: ‘I just followed where the energy was’May 13, 2025 | msn.com2 Intriguing Internet Stocks to Buy Now: TRVG, UPWKMay 9, 2025 | zacks.comTrivago N.V. ADS (TRVG) Is Up 42.86% in One Week: What You Should KnowMay 9, 2025 | zacks.comTrivago (TRVG) Shows Fast-paced Momentum But Is Still a Bargain StockMay 9, 2025 | zacks.comDemystifying trivago: Insights From 5 Analyst ReviewsMay 6, 2025 | benzinga.comAnalysts Offer Insights on Communication Services Companies: trivago (TRVG) and Meta Platforms (META)May 2, 2025 | theglobeandmail.comB. Riley Securities Upgrades trivago N.V. - Depositary Receipt () (TRVG)May 2, 2025 | msn.comtrivago NV (TRVG) Q1 2025 Earnings Call Highlights: Revenue Surge Amid Strategic InvestmentsMay 1, 2025 | finance.yahoo.comtrivago N.V.: trivago Delivers 22% Revenue Growth and Raises Full-Year GuidanceApril 30, 2025 | finanznachrichten.deWhy These 15 Communication Services Stocks Are up the Most So Far in 2025April 30, 2025 | insidermonkey.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCTM, NRC, TRVG, and OABI Company DescriptionsCastellum NYSEAMERICAN:CTM$1.07 +0.04 (+3.88%) Closing price 06/23/2025 04:10 PM EasternExtended Trading$1.08 +0.01 (+0.93%) As of 05:19 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Castellum, Inc. provides services in the areas of cybersecurity, information technology, electronic and information warfare, and information operations. Its services include intelligence analysis, software development, software engineering, program management, strategic and mission planning, information assurance, cybersecurity and policy support, data analytics, and model based systems engineering services. It serves customers in the federal government, financial services, healthcare, and other data application sectors. The company is based in Bethesda, Maryland.National Research NASDAQ:NRC$17.00 +0.45 (+2.72%) Closing price 06/23/2025 04:00 PM EasternExtended Trading$17.50 +0.50 (+2.94%) As of 06/23/2025 07:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. The company also offers marketing solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.OmniAb NASDAQ:OABI$1.61 +0.02 (+1.26%) Closing price 06/23/2025 04:00 PM EasternExtended Trading$1.61 0.00 (0.00%) As of 06/23/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.OmniAb, Inc., a biotechnology company, engages in the discovery and provision of therapeutic antibody discovery technologies in the United States. The company's technology platform creates and screens diverse antibody repertoires and identify optimal antibodies for partners' drug development efforts. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company's OmniFlic, a bispecific rat, and OmniClic, a bispecific chicken, designed for discovery of bispecific antibody applications; OmniTaur, which provides unique structural characteristics of cow antibodies for complex targets; and OmniDeep, a suite of in silico, an AI and machine learning tools for therapeutic discovery and optimization through various technologies and capabilities. OmniAb, Inc. was founded in 2012 and is headquartered in Emeryville, California.Trivago N.V. ADS NASDAQ:TRVG$3.83 -0.05 (-1.29%) Closing price 06/23/2025 04:00 PM EasternExtended Trading$3.71 -0.12 (-3.16%) As of 06/23/2025 06:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.trivago N.V., together with its subsidiaries, operates a hotel and accommodation search platform in the United States, Germany, the United Kingdom, Canada, Japan, and internationally. It offers an online meta-search for hotels and accommodation through online travel agencies, hotel chains, and independent hotels. The company provides travel search for different types of accommodations, such as hotels, vacation rentals, and apartments; and enable advertiser access through website and apps. In addition, it offers access to its platform through various localized websites and apps in various languages. The company was incorporated in 2005 and is headquartered in Düsseldorf, Germany. trivago N.V. operates as a subsidiary of Expedia Lodging Partner Services Sarl. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Microsoft Stock Holds Steady as AI Drives Workforce Shift Top International ETFs With Dividends and Market-Beating Returns D-Wave Goes International With South Korea Partnership BigBear.ai Poised to Benefit as Palantir Dominates AI Defense Kroger Stock Confirms Buy Signal as Uptrend Gains Strength Darden Stock Set to Sizzle After Blowout Q4 and $1B Buyback Alphabet’s Comeback: The Hidden Engines Powering Google New All-Time Highs Coming for Broadcom? Wall Street Says Yes Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
